Brief: Guardant Health Q4 Adjusted EPS USD -0.5 Vs. IBES Estimate USD -0.7
19/02/2026 21:05
Feb 19 (Reuters) - Guardant Health Q4 adjusted net income USD -63.8 million vs. IBES estimate USD -93.2 million. Q4 adjusted EBITDA USD -64.9 million vs. IBES estimate USD -49.9 million Q4 EPS USD -1 outlook FY revenue USD 1,250-1,280 million
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte